Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: A study by the national cancer institute organ dysfunction working group

Joseph Gibbons, Merrill J. Egorin, Ramesh K. Ramanathan, Pingfu Fu, Daniel L. Mulkerin, Stephen Shibata, Chris H.M. Takimoto, Sridhar Mani, Patricia A. LoRusso, Jean L. Grem, Anna Pavlick, Heinz Josef Lenz, Susan M. Flick, Sherrie Reynolds, Theodore F. Lagattuta, Robert A. Parise, Yanfeng Wang, Anthony J. Murgo, S. Percy Ivy, Scot C. Remick

Research output: Contribution to journal › Article › peer-review

89 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I and pharmacokinetic study of imatinib mesylate in patients with advanced malignancies and varying degrees of renal dysfunction: A study by the national cancer institute organ dysfunction working group'. Together they form a unique fingerprint.

Medicine & Life Sciences